Tag: Therapeutics

Blue Earth Therapeutics Closes $76.5M Series A Financing

Blue Earth Therapeutics Ltd, an Oxford, UK-based chief within the growth of therapeutic radiopharmaceuticals, closed a $76.5M Collection A financing. The

By saad

AbbVie to Acquire Aliada Therapeutics

AbbVie (NYSE: ABBV), Chicago, IL-based acquired Aliada Therapeutics, a Boston, MA-based biotechnology firm targeted on central nervous system (CNS) illnesses.

By saad

Nob Hill Therapeutics Raises $3M in Series A Funding

Nob Hill Therapeutics dry powder nebulizer (DryNeb) Nob Hill Therapeutics, an Albuquerque, NM-based an early-stage pulmonary medical system

By saad

Nammi Therapeutics Completes Series B Funding

Nammi Therapeutics, Inc., a Los Angeles, CA-based immuno-oncology firm, acquired $1M in funding dedication by the Myeloma Funding Fund

By saad

Montara Therapeutics Closes $8M Seed Funding

Montara Therapeutics, Inc., a San Francisco, CA-based therapeutics firm aiming to advance brain-targeting medicine, closed an $8m seed

By saad

LTZ Therapeutics Raises Over $20M in Series A Financing

LTZ Therapeutics, a Redwood Metropolis, CA- and Shenzen, China-based immunotherapy-focused biotech firm, closed its Collection A financing of

By saad

Confo Therapeutics Raises EUR 60M in Series B Financing

Confo Therapeutics, a Ghent, Belgium-based clinical-stage firm and innovator within the discovery of medicines concentrating on G-protein coupled

By saad

Rona Therapeutics Raises $35M Series A+ Financing

Rona Therapeutics, a Shanghai, China-based scientific stage platform firm which makes a speciality of nucleic acid drug analysis

By saad

Anbogen Therapeutics Raises USD 7.5M in Series A+ Funding

Anbogen Therapeutics, Inc., a Taipei, Taiwan-based clinical-stage firm creating most cancers therapies, raised USD 7.3M in Collection A+

By saad

Coeptis Therapeutics Closes $4.3M Series A Funding

Coeptis Therapeutics (Nasdaq: COEP), a Wexford, PA-based biopharmaceutical firm growing revolutionary cell remedy platforms for most cancers, autoimmune, and

By saad

Radiomer Therapeutics Raises Pre-Seed Funding

Radiomer Therapeutics, a Houston, TX-based Fannin Companions-founded firm that's creating focused radiopharmaceuticals / radioligand therapies for theranostic purposes, has

By saad

Progentos Therapeutics Closes $65M Series A Financing

Progentos Therapeutics, a Watertown, MA-based biotech firm addressing the necessity to regenerate myelin and restore operate for sufferers

By saad